In sync with its strategy to expand in the medical sector, Avery Dennison Corporation (AVY - Free Report) has acquired Longford, Ireland-based Finesse Medical, a maker of materials used for wound care and skin treatments.
Finesse Medical specializes in the development and application of advanced technologies in wound care and skin treatment. This includes skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. It is a key supplier to global healthcare-product original equipment manufacturers and also provides contract manufacturing and product development services. The company generated revenues of around $17 million last year.
Finesse Medical is a strategic fit with Avery Dennison’s Vancive Medical Technologies. Vancive Medical Technologies was previously reported as a standalone segment but now comes under the Industrial and Healthcare Materials segment which generated 7% of Avery Dennison’s revenues in the first quarter of 2017. Finesse Medical’s product portfolio of silicone gels and polyurethane foam dressings will complement Avery Dennison’s products in wound care. Further, its converting and packaging capabilities will enable Avery Dennison to offer expanded manufacturing services to customers.
Avery Dennison Corporation Price
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
In sync with its strategy to expand in the medical sector, Avery Dennison Corporation (AVY - Free Report) has acquired Longford, Ireland-based Finesse Medical, a maker of materials used for wound care and skin treatments.
Finesse Medical specializes in the development and application of advanced technologies in wound care and skin treatment. This includes skin barrier films and protection creams, and silicone and polyurethane foam wound dressings. It is a key supplier to global healthcare-product original equipment manufacturers and also provides contract manufacturing and product development services. The company generated revenues of around $17 million last year.
Finesse Medical is a strategic fit with Avery Dennison’s Vancive Medical Technologies. Vancive Medical Technologies was previously reported as a standalone segment but now comes under the Industrial and Healthcare Materials segment which generated 7% of Avery Dennison’s revenues in the first quarter of 2017. Finesse Medical’s product portfolio of silicone gels and polyurethane foam dressings will complement Avery Dennison’s products in wound care. Further, its converting and packaging capabilities will enable Avery Dennison to offer expanded manufacturing services to customers.
Avery Dennison Corporation Price
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on PH - FREE
Get the latest research report on AVY - FREE
Get the latest research report on AGCO - FREE